{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:05:12Z","timestamp":1773738312342,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T00:00:00Z","timestamp":1039564800000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Urology"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold> Nerve\u2010sparing techniques are commonly used in retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular germ cell tumors to preserve postoperative ejaculation. The indications for nerve\u2010sparing procedures have been extended to patients who have residual retroperitoneal tumor postchemotherapy with an increase in the incidence of local recurrence. Here, we report on 26 Japanese men with advanced testicular cancer who underwent nerve\u2010sparing RPLND after partially successful chemotherapy.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>  Between January 1995 and December 2000, 26 patients with metastatic or recurrent testicular cancer underwent nerve\u2010sparing RPLND after chemotherapy. Eight patients had seminoma and 18 had non\u2010seminoma. Three patients received high\u2010dose chemotherapy with carboplatin (250\u2003mg\/m<jats:sup>2<\/jats:sup> per day\u2003\u00d7\u20035 days), etoposide (300\u2003mg\/m<jats:sup>2<\/jats:sup> per day\u2003\u00d7\u20035 days) and ifosfamide (1.5\u2003g\/m<jats:sup>2<\/jats:sup> per day\u2003\u00d7\u20035 days) in combination with peripheral blood stem cell transplantation.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In all cases, lumbar splanchnic nerves were preserved macroscopically during the operation, at least unilaterally. Twenty\u2010two patients (84.6%) achieved antegrade ejaculation during a mean follow\u2010up at 3.9 months (range: 1\u20137 months). Three patients have fathered children. Only one patient suffered a retroperitoneal recurrence during a median follow\u2010up at 25.8 months (range: 6\u201376 months).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Nerve\u2010sparing procedures for RPLND are appropriate for patients with metastatic testicular cancer, even after chemotherapy. The procedure preserves ejaculatory function in the majority of the patients without increasing the risk of local recurrence. Nerve\u2010sparing RPLND improves the quality of life in patients who require postchemotherapy RPLND to treat residual tumor.<\/jats:p>","DOI":"10.1046\/j.1442-2042.2002.00520.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:05:50Z","timestamp":1047434750000},"page":"539-544","source":"Crossref","is-referenced-by-count":25,"title":["Nerve\u2010sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy"],"prefix":"10.1111","volume":"9","author":[{"given":"NORIO","family":"NONOMURA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUO","family":"NISHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NATSUKI","family":"TAKAHA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HITOSHI","family":"INOUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKESHI","family":"NOMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOUICHI","family":"MIZUTANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIRO","family":"NAKAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHIKO","family":"OKUYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TSUNEHARU","family":"MIKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,11]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)55029-6"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53996-8"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1444"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42869-2"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(17)39435-1","article-title":"Nerve\u2010preserving bilateral retroperitoneal lymphadenectomy: anatomical study and operative approach","volume":"144","author":"Colleselli K","year":"1990","journal-title":"J. Urol."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39434-X"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0094-0143(21)01555-X","article-title":"Fertility issues in the treatment of nonseminomatous testicular tumors","volume":"14","author":"Lange PH","year":"1987","journal-title":"Urol. Clin. North Am."},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)32755-6"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000475283","article-title":"Preservation of antegrade ejaculation in retroperitoneal lymphadenectomy due to residual masses after primary chemotherapy for testicular carcinoma","volume":"25","author":"Solsona E","year":"1994","journal-title":"Eur. Urol."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65476-4"},{"key":"e_1_2_5_12_2","volume-title":"General Rules for Clinical and Pathological Studies on Testicular Tumors","author":"The Japanese Urological Association and the Japanese Pathological Society.","year":"1997"},{"key":"e_1_2_5_13_2","first-page":"3410","volume-title":"Campbell's Urology","author":"Skinner EC","year":"1998"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.1997.tb00291.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.3.179"},{"key":"e_1_2_5_16_2","first-page":"128","article-title":"Toxicity of treatment of germ cell tumors","volume":"19","author":"Boyer M","year":"1992","journal-title":"Semin. Oncol."}],"container-title":["International Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-2042.2002.00520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-2042.2002.00520.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:49:46Z","timestamp":1697327386000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-2042.2002.00520.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1046\/j.1442-2042.2002.00520.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-2042.2002.00520.x","archive":["Portico"],"relation":{},"ISSN":["0919-8172","1442-2042"],"issn-type":[{"value":"0919-8172","type":"print"},{"value":"1442-2042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}